Anderson’s intestinal tissue was retained by the hospital as standard pathological practice, not with any awareness that it would later be used for genetic identification. The testing conducted in 1994 used material she had not donated for research purposes. She had been cremated at her death, which may or may not have reflected any intention to limit later investigation of her biological identity.
The ethical framework for the use of retained tissue in forensic and historical research has evolved considerably since 1994. Current standards in many jurisdictions require institutional review, consent where possible, and careful handling of potentially sensitive findings. The 1994 Anderson testing predated the widespread adoption of these frameworks.
This does not mean the testing was wrong, or that its results are invalid. The question of Anderson’s identity was a matter of public record and active litigation for decades; the resolution of that question served both historical accuracy and the interests of communities that had organized around it. But the retrospective use of pathological tissue for identity determination sits at an ethically complex intersection of patient privacy, historical inquiry, and scientific capability.
The practical outcome of the testing — the exclusion of the Romanov claim and the support for the Schanzkowska identification — is scientifically valid. The biological findings stand regardless of the ethical questions surrounding how they were obtained.
—
## The 1995 Paper and What It Actually Established
The study published in Nature Genetics in January 1995 — Stoneking and colleagues, “Establishing the identity of Anna Anderson Manahan” — is the primary scientific citation for the DNA findings in the Anderson case.